Jagsonpal Pharmaceuticals Ltd
JAGSNPHARM
Company Profile
Business description
Jagsonpal Pharmaceuticals Ltd is a pharmaceutical company engaged in the manufacturing and trading of pharmaceutical formulations and active pharmaceutical ingredients (APIs). Its portfolio covers therapeutic areas including Gynaecology, Orthopaedics, Dermatology and Paediatrics, with Gynaecology and Orthopaedics forming its core areas of focus. The company offers a range of pharmaceutical formulations, and its brands include Lycored, Maintane, Doxypal DR, Indocap and others.
Contact
Phase - IV, Udyog Vihar
Plot No. 412-415, Nimai Tower, 3rd Floor
Sector 18
GurugramHR122015
INDT: +91 1244406710
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2027
Employees
1,410
Stocks News & Analysis
stocks
ASX share undervalued despite margin woes
Short term margin pressure yet shares remain undervalued on improved outlook.
stocks
A better way to predict long-term stock returns
A value-weighted version of the CAPE ratio corrects a structural flaw and delivers stronger forecasts of long-term stock returns.
stocks
Five star stock added to August best ideas list
Morningstar analysts hand pick this undervalued opportunity for their August global best ideas.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,923.90 | 3.70 | 0.04% |
| CAC 40 | 8,117.78 | 61.99 | -0.76% |
| DAX 40 | 25,440.81 | 127.75 | -0.50% |
| Dow JONES (US) | 52,463.77 | 109.52 | -0.21% |
| FTSE 100 | 10,697.57 | 47.13 | 0.44% |
| HKSE | 24,917.60 | 111.97 | 0.45% |
| NASDAQ | 26,255.04 | 78.00 | -0.30% |
| Nikkei 225 | 63,492.99 | 518.35 | -0.81% |
| NZX 50 Index | 13,560.69 | 19.64 | -0.14% |
| S&P 500 | 7,631.22 | 25.76 | -0.34% |
| S&P/ASX 200 | 8,749.90 | 8.70 | 0.10% |
| SSE Composite Index | 3,885.33 | 2.78 | -0.07% |